These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8941077)

  • 1. Serum 3 alpha-androstanediol-glucuronide is decreased in nonhirsute women with acne vulgaris.
    Joura EA; Geusau A; Schneider B; Söregi G; Huber JC
    Fertil Steril; 1996 Dec; 66(6):1033-5. PubMed ID: 8941077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum androsterone conjugates differentiate between acne and hirsutism in hyperandrogenic women.
    Carmina E; Stanczyk FZ; Matteri RK; Lobo RA
    Fertil Steril; 1991 May; 55(5):872-6. PubMed ID: 1827073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two different pathogenetic mechanisms may play a role in acne and in hirsutism.
    Toscano V; Balducci R; Bianchi P; Guglielmi R; Mangiantini A; Rossi FG; Colonna LM; Sciarra F
    Clin Endocrinol (Oxf); 1993 Nov; 39(5):551-6. PubMed ID: 8252744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue production of androgens in women with acne.
    Lookingbill DP; Horton R; Demers LM; Egan N; Marks JG; Santen RJ
    J Am Acad Dermatol; 1985 Mar; 12(3):481-7. PubMed ID: 3157707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of serum 3 alpha-androstanediol glucuronide with acne and chest hair density in men.
    Lookingbill DP; Egan N; Santen RJ; Demers LM
    J Clin Endocrinol Metab; 1988 Nov; 67(5):986-91. PubMed ID: 2972739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is 3 alpha, 17 beta-androstanediol-glucuronide a diagnostic marker in women with androgenic manifestations?
    Vogt C; Dericks-Tan JS; Kuhl H; Taubert HD
    Gynecol Endocrinol; 1992 Jun; 6(2):85-90. PubMed ID: 1386956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects.
    Meczekalski B; Slopien R; Warenik-Szymankiewicz A
    Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):88-92. PubMed ID: 16979812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acne in adult women and the markers of peripheral 3 alpha-diol G activity.
    Cunha MG; Martins CP; M Filho CD; Alves BC; Adami F; Azzalis LA; Fonseca FL
    J Cosmet Dermatol; 2016 Dec; 15(4):330-334. PubMed ID: 27272708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of androstanediol glucuronide, total testosterone, and free testosterone in hirsute women.
    Khoury MY; Baracat EC; Pardini DP; Vieira JG; de Lima GR
    Fertil Steril; 1994 Jul; 62(1):76-80. PubMed ID: 8005308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum androstanediol glucuronide in women with facial hirsutism.
    Salman K; Spielvogel RL; Shulman LH; Miller JL; Vanderlinde RE; Rose LI
    J Am Acad Dermatol; 1992 Mar; 26(3 Pt 2):411-4. PubMed ID: 1564146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of 5 alpha-reductase activity in hirsute women: comparison of serum androstanediol glucuronide with urinary androsterone and aetiocholanolone excretion.
    Gilad S; Chayen R; Tordjman K; Kisch E; Stern N
    Clin Endocrinol (Oxf); 1994 Apr; 40(4):459-64. PubMed ID: 8187312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome.
    Lobo RA; Goebelsmann U; Horton R
    J Clin Endocrinol Metab; 1983 Aug; 57(2):393-7. PubMed ID: 6223045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous application of an androstenedione gel as an in vivo test of 5 alpha-reductase activity in women.
    Miles RA; Cassidenti DL; Carmina E; Gentzschein E; Stanczyk FZ; Lobo RA
    Fertil Steril; 1992 Oct; 58(4):708-12. PubMed ID: 1426314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of isotretinoin on serum levels of precursor and peripherally derived androgens in patients with acne.
    Lookingbill DP; Demers LM; Tigelaar RE; Shalita AR
    Arch Dermatol; 1988 Apr; 124(4):540-3. PubMed ID: 2965551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen sulfate and glucuronide conjugates in nonhirsute and hirsute women with polycystic ovarian syndrome.
    Matteri RK; Stanczyk FZ; Gentzschein EE; Delgado C; Lobo RA
    Am J Obstet Gynecol; 1989 Dec; 161(6 Pt 1):1704-9. PubMed ID: 2532471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androsterone sulfate: physiology and clinical significance in hirsute women.
    Zwicker H; Rittmaster RS
    J Clin Endocrinol Metab; 1993 Jan; 76(1):112-6. PubMed ID: 8380602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased free testosterone but normal 5 alpha-reduced testosterone metabolites in obese premenopausal women.
    Giagulli VA; De Pergola G; Giorgino F; Cignarelli M; Abbaticchio G; Vermeulen A; Giorgino R
    Clin Endocrinol (Oxf); 1992 Jun; 36(6):553-8. PubMed ID: 1424180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in androgen conjugate levels in women and men with alopecia.
    Legro RS; Carmina E; Stanczyk FZ; Gentzschein E; Lobo RA
    Fertil Steril; 1994 Oct; 62(4):744-50. PubMed ID: 7926083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel.
    Lemay A; Dewailly SD; Grenier R; Huard J
    J Clin Endocrinol Metab; 1990 Jul; 71(1):8-14. PubMed ID: 2142494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substrate dependency of C19 conjugates in hirsute hyperandrogenic women and the influence of adrenal androgen.
    Carmina E; Gentzschein E; Stanczyk FZ; Lobo RA
    Hum Reprod; 1995 Feb; 10(2):299-303. PubMed ID: 7769052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.